Pilot Pharmacokinetic Study of High-Dose Daptomycin in Hemodialysis Patients With Infected Medical Devices

Am J Kidney Dis. 2017 Nov;70(5):732-734. doi: 10.1053/j.ajkd.2017.05.011. Epub 2017 Jun 21.

Authors

Jérémie Diolez¹, Nicolas Venisse², Simohamed Belmouaz¹, Marc-André Bauwens¹, Frank Bridoux¹, Guillaume Beraud³

Affiliations

¹ Centre Hospitalier Universitaire de Poitiers, Poitiers, France.
² Centre Hospitalier Universitaire de Poitiers, Poitiers, France; INSERM, Poitiers, France.
³ Centre Hospitalier Universitaire de Poitiers, Poitiers, France; Université Droit et Santé Lille 2, Lille, France; Hasselt University, Hasselt, Belgium.

PMID: 28645706
DOI: 10.1053/j.ajkd.2017.05.011

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Anti-Bacterial Agents / administration & dosage
Anti-Bacterial Agents / pharmacokinetics
Bacterial Infections / drug therapy*
Bacterial Infections / etiology
Bacterial Infections / metabolism
Catheter-Related Infections / drug therapy*
Catheter-Related Infections / etiology
Daptomycin / administration & dosage
Daptomycin / pharmacokinetics*
Dose-Response Relationship, Drug
Female
Humans
Male
Middle Aged
Pilot Projects
Prospective Studies
Renal Dialysis / adverse effects
Renal Dialysis / instrumentation*

Substances

Anti-Bacterial Agents
Daptomycin